Cell Communication and Signaling,
Journal Year:
2024,
Volume and Issue:
22(1)
Published: Nov. 8, 2024
Cardiorenal
diseases
represent
a
complex
interplay
between
heart
failure
and
renal
dysfunction,
being
clinically
classified
as
cardiorenal
syndromes
(CRS).
Recently,
the
contributions
of
altered
nicotinamide
adenine
dinucleotide
(NAD
BMC Anesthesiology,
Journal Year:
2024,
Volume and Issue:
24(1)
Published: March 23, 2024
Abstract
Background
Chronic
heart
failure
(HF)
is
a
common
clinical
condition
associated
with
adverse
outcomes
in
elderly
patients
undergoing
non-cardiac
surgery.
This
study
aimed
to
estimate
clinically
applicable
NT-proBNP
cut-off
that
predicts
postoperative
30-day
morbidity
surgical
cohort.
Methods
One
hundred
ninety-nine
consecutive
older
than
65
years
elective
surgery
intermediate
or
high
risk
were
analysed.
Preoperative
was
measured,
and
events
assessed
up
day
30.
The
primary
endpoint
the
composite
(CME)
consisting
of
rehospitalisation,
acute
decompensated
(ADHF),
kidney
injury
(AKI),
infection
at
Secondary
endpoints
included
perioperative
fluid
balance
incidence,
duration,
severity
hypotension.
Results
443
pg/ml
had
highest
accuracy
predicting
endpoint;
450
implemented
compare
endpoints.
Although
35.2%
above
threshold,
only
10.6%
known
history
HF.
infection.
Event
rates
significantly
increased
>
(70.7%
vs.
32.4%,
p
<
0.001),
which
due
incidence
cardiac
rehospitalisation
(4.4%
0%,
=
0.018),
ADHF
(20.1%
4.0%,
AKI
(39.8%
8.3%,
(46.3%
24.4%,
0.01).
Perioperative
hypotension
comparable
between
groups.
an
independent
predictor
CME
multivariable
Cox
regression
model
(hazard
ratio
2.92
[1.72–4.94]).
Conclusions
Patients
exhibited
profoundly
morbidity.
Further
studies
should
focus
on
interdisciplinary
approaches
improve
through
integrated
interventions
period.
Trial
registration
German
Clinical
Trials
Register:
DRKS00027871,
17/01/2022
Frontiers in Cell and Developmental Biology,
Journal Year:
2024,
Volume and Issue:
12
Published: Oct. 9, 2024
This
article
reviews
the
latest
research
progress
on
role
of
mitochondrial
autophagy
receptor
FUN14
domain
containing
1
(FUNDC1)
in
events
and
kidney
disease.
FUNDC1
is
a
protein
located
outer
membrane
mitochondria,
which
maintains
function
quality
mitochondria
by
regulating
autophagy,
that
is,
selective
degradation
process
mitochondria.
The
structural
characteristics
enable
it
to
respond
intracellular
signal
changes
regulate
activity
through
phosphorylation
dephosphorylation.
During
phosphorylation,
unc-51-like
kinase
(ULK1)
promotes
activation
mitophagy
phosphorylating
Ser17
FUNDC1.
In
contrast,
Src
CK2
kinases
inhibit
interaction
between
LC3
Tyr18
Ser13,
thereby
inhibiting
mitophagy.
dephosphorylation,
PGAM5
phosphatase
enhances
dephosphorylating
activating
BCL2L1
inhibits
interacting
with
PGAM5,
preventing
dephosphorylation
plays
an
important
events,
participating
fission,
maintaining
homeostasis
iron
proteins
matrix,
mediating
crosstalk
endoplasmic
reticulum
lysosomes,
have
effects
cell
energy
metabolism
programmed
death.
aspect
disease,
abnormal
closely
related
occurrence
development
many
diseases.
acute
injury
(AKI),
cardiorenal
syndrome
(CRS),
diabetic
nephropathy
(DN),
chronic
disease
(CKD)
,renal
fibrosis
(RF)
renal
anemia,
FUNDC1-mediated
imbalance
may
be
one
key
factors
progression.
Therefore,
in-depth
study
regulatory
mechanism
great
significance
for
understanding
pathogenesis
developing
new
treatment
strategies.
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(6), P. 2456 - 2456
Published: March 10, 2025
Heart
failure
(HF)
is
a
major
health
problem
because
of
its
high
prevalence,
morbidity,
mortality,
and
cost
care.
An
important
contributor
to
morbidity
mortality
in
patients
with
advanced
HF
kidney
dysfunction.
Almost
half
develop
cardiorenal
syndrome
(CRS).
The
management
complicated
by
CRS
challenging.
Two
main
strategies
have
been
widely
accepted
for
the
CRS,
namely
improving
cardiac
output
relieving
congestion.
Diuretics
remain
cornerstone
first-line
therapy
decongestion;
however,
substantial
number
diuretic
resistance.
In
face
persistent
congestion
progressive
deterioration
function,
implementation
replacement
may
become
only
solution.
review
current
evidence
on
extracorporeal
peritoneal-based
techniques
are
presented.
Frontiers in Nutrition,
Journal Year:
2025,
Volume and Issue:
12
Published: March 13, 2025
Background
Cardiorenal
syndrome
(CRS)
represents
a
burgeoning
global
health
concern
characterized
by
its
increasing
prevalence.
Life’s
Crucial
9
(LC9),
an
innovative
tool
for
cardiovascular
assessment,
and
the
Dietary
Inflammatory
Index
(DII),
which
quantifies
diet’s
impact
on
body
inflammation,
have
not
been
previously
studied
in
conjunction
regarding
their
association
with
CRS.
Objective
This
study
aims
to
explore
relationship
between
LC9
CRS,
using
data
from
National
Health
Nutrition
Examination
Survey
(NHANES),
examine
whether
DII
serves
as
mediator
this
association.
Methods
research
included
25,792
NHANES
participants
spanning
2005
2018.
The
leverages
dataset’s
comprehensive
representativeness
robust
statistical
power
ensure
generalizable
reliable
findings.
We
employed
weighted
logistic
regression
evaluate
scores
CRS
presence,
conducted
subgroup
analyses,
performed
mediation
analysis
investigate
role
of
DII.
Results
Our
demonstrated
significant
inverse
Upon
controlling
confounders,
each
10-point
rise
correlates
26%
reduction
prevalence
(
p
<
0.001).
Additionally,
stratifying
into
tertiles
T1
reference
group
revealed
that
T2
(OR
=
0.59,
95%
CI
0.48–0.72,
0.001)
T3
0.57,
0.38–0.88,
exhibited
strong
negative
correlation
trend.
dose–response
curve
illustrates
linear
CRS;
increases,
occurrence
decreases.
shows
positive
connection
0.001),
but
indicates
decreasing
trend
when
rises
β
−0.65,
Mediation
reveals
mediates
proportion
12.5%
Conclusion
findings
indicate
incidence,
is
associated
relationship.
suggests
potential
preventive
strategies
against
through
lifestyle
modifications
guided
LC9.
Annals of Medical Science and Research,
Journal Year:
2025,
Volume and Issue:
4(1), P. 4 - 10
Published: Jan. 1, 2025
Abstract
Cardiorenal
metabolic
syndrome
(CRMS)
is
emerging
as
a
health
crisis
in
the
Indian
population,
marked
by
interplay
of
cardiovascular
disease,
renal
dysfunction,
and
disorders.
This
study
delves
into
multifaceted
nature
CRMS,
highlighting
its
rising
prevalence
driven
lifestyle
changes,
urbanization,
dietary
habits.
With
growing
burden
obesity,
hypertension,
diabetes,
demographic
faces
unique
challenges
that
exacerbate
risk
CRMS.
The
explores
pathophysiological
mechanisms
underlying
this
syndrome,
emphasizing
interdependence
heart,
kidney,
health.
Effective
screening
strategies
tailored
to
context,
including
use
anthropometric
measurements
comprehensive
panels,
are
vital
for
early
detection
intervention.
discussion
extends
pharmacological
nonpharmacological
management
approaches,
underscoring
importance
modifications
alongside
medication
adherence.
Community
engagement
education
pivotal
fostering
awareness
promoting
preventive
measures.
By
analyzing
implications
CRMS
on
public
health,
aims
illuminate
urgent
need
integrated
healthcare
solutions
policy
initiatives
address
faced
population.
Ultimately,
it
advocates
framework
combines
appropriate
research,
prevention
methods,
combat
threat
ensuring
healthier
future
individuals
communities
across
India.
The Journal of Physiology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 11, 2025
Abstract
Autosomal
recessive
polycystic
kidney
disease
(ARPKD)
is
a
congenital
hepatorenal
fibrocystic
pathology
and
one
of
the
most
significant
childhood
nephropathies
leading
to
chronic
(CKD).
While
damage
has
been
well
studied
in
this
pathology,
only
few
studies
have
investigated
specific
cardiac
during
ARPKD.
This
study
aimed
conduct
large
analysis
heart
dysfunction
progression
CKD.
ARPKD
rats
with
Pkhd1
gene
mutation
(IVS35‐2A>T)
were
monitored
for
CKD
via
echocardiography.
Heart
fibrosis
was
assessed
using
Sirius
red
staining,
cardiokines
mRNA
expressions
tissue
analysed.
exhibited
increased
blood
pressure,
hypertrophy
thickening
left
ventricular
posterior
wall,
correlated
elevated
plasma
creatinine
levels.
Diastolic
evident,
shown
by
altered
E
/
A
e
′
ratios,
which
worsened
severity.
renal
dysfunction,
signalling
pathways
activated,
marked
galectin‐3,
collagen‐1,
fibroblast
growth
factor
23,
suppressor
tumorigenicity
2
(ST2)
soluble
ST2
expression.
Growth
differentiation
15
levels
rose
progression,
while
Irisin
decreased,
negatively
correlating
ratio.
highlights
diastolic
fibrosis,
severe
These
changes
are
linked
dysregulation
cardiokine
signalling,
providing
new
insights
into
uraemia‐induced
failure
image
Key
points
rare
genetic
disorder
reduced
life
expectancy
broad
clinical
spectrum
including
systemic
hypertension,
failure,
portal
hepatic
fibrosis.
PCK
spontaneous
gene,
same
affected
human
develop
cysts
other
manifestations
Changes
(fibrosis,
hypertrophy)
(decreasing
increasing
ratios)
worsen
rats.
dysfunctions
associated
such
as
Irisin,
could
be
marker
function
patients.
Journal of Clinical Medicine,
Journal Year:
2025,
Volume and Issue:
14(9), P. 2996 - 2996
Published: April 26, 2025
Cardiorenal
syndrome
(CRS)
is
a
challenging
condition
characterised
by
interdependent
dysfunction
of
the
heart
and
kidneys.
Despite
advancements
in
understanding
its
pathophysiology,
clinical
management
remains
complex
due
to
overlapping
mechanisms
high
rates
diuretic
resistance.
Relevant
literature
was
identified
through
comprehensive
narrative
review
PubMed,
Embase,
Cochrane
Library
databases,
focusing
on
pivotal
trials
relating
CRS
from
2005
2024.
This
aims
provide
pragmatic,
evidence-based
approach
acute
addressing
common
misconceptions,
outlining
diagnostic
strategies,
proposing
structured
algorithm
manage
We
discuss
role
thoracic
venous
excess
ultrasound
(VeXUS)
providing
reliable
measures
systemic
congestion,
natriuresis-guided
sequential
nephron
blockade,
more
targeted
therapies,
including
ultrafiltration
refractory
cases.
In
addition,
we
explore
emerging
that
target
renal
hypoperfusion
congestion
CRS.
Designed
for
broad
audience,
general
physicians,
cardiologists,
nephrologists,
this
integrates
evidence
with
practical
guidance
support
effective
timely
decision-making
care
patients
Frontiers in Bioscience-Landmark,
Journal Year:
2025,
Volume and Issue:
30(5)
Published: April 30, 2025
Background:
Type
2
cardiorenal
syndrome
(CRS)
is
a
complex
disease
characterized
by
the
interplay
between
heart
and
kidneys.
The
pathophysiology
of
type
CRS
involves
multiple
molecular
signaling
pathways.
Transient
receptor
potential
melastatin
(TRPM2)
reactive
oxygen
species
(ROS)-sensitive
non-selective
calcium-permeable
cation
channel,
which
plays
regulatory
role
in
intracellular
Ca2+
homeostasis.
Thus,
this
study
aimed
to
explore
biological
functions
mechanisms
ROS–TRPM2
axis
CRS.
Methods:
model
rats
(a
rat
induced
through
left
anterior
descending
coronary
artery
ligation
combined
with
5/6
total
nephrectomy)
lipopolysaccharide
(LPS)-induced
cell
lines,
human
kidney-2
(HK-2),
were
transfected
small
interfering
RNA
(siRNA)
knock
down
TRPM2
or
calcium
ion
channel
activator
Yoda1
evaluate
involvement
on
Changes
kidney
tissue
morphology
observed
using
H&E
staining;
viability
apoptosis
monitored
CCK-8,
Annexin
V-FITC/PI,
TUNEL
kits,
alongside
quantitative
real-time
polymerase
chain
reaction
(qRT-PCR),
Western
blot,
ELISA,
immunofluorescence
assays
confirm
interaction
ROS,
TRPM2,
Ca2+.
Results:
highly
expressed
HK-2
cells
after
LPS
stimulation
renal
tissues
rats.
Intervention
via
improves
injured
viability,
mitigates
apoptosis,
inhibits
inflammatory
cytokines
interleukin
10
(IL-10)
tumor
necrosis
factor-α
(TNF-α),
as
well
indices
oxidative
stress—malondialdehyde
(MDA)
ROS—promotes
antioxidant
capacity
(T-AOC)
expression,
alleviates
pathological
changes
CRS;
promoted
contrasting
effect
deletion.
Conclusions:
abnormally
damaged
kidneys
during
pathogenesis
Silencing
can
inhibit
stress
responses,
reduce
promote
survival,
alleviate
loss;
may
be
related
inhibition
influx.
This
suggests
that
pathway
significant
for
development,
an
effective
therapeutic
target